Affiliation:
1. Xiangya Hospital, Central South University
2. Xiangya Hospital
Abstract
Abstract
This study aimed to investigate the causal associations of brain structure with bone mineral density (BMD). Based on the genome-wide association studies (GWAS) summary statistics of 1325 brain imaging-derived phenotypes (BIDPs) of brain structure from the UK Biobank, and GWAS summary datasets of 5 BMD locations, including total body, femoral neck, lumbar spine, forearm, and heel from GEFOS Consortium, linkage disequilibrium score regression (LDSC) was conducted to determine the genetic correlations and Mendelian randomization (MR) was then performed to explore the causal relationship between the BIDPs and BMD. Several sensitivity analyses were performed to verify the strength and stability of the present MR outcomes. To increase confidence in our findings, we also performed a confirmatory MR between BIDPs and osteoporosis. LDSC revealed that 1.93% of BIDPs, with a false discovery rate (FDR) < 0.01, genetically correlated with BMD. Additionally, we observed that 1.31% of BIDPs exhibited a significant causal relationship with BMD (FDR < 0.01) through MR. Both the LDSC and MR results demonstrated that the BIDPs “Volume of normalized brain”, “Volume of grey matter in Left Inferior Frontal Gyrus, pars opercularis”, “Volume of Estimated Total Intra Cranial” and “Volume-ratio of brain segmentation/estimated total intracranial” had strong associations with BMD. Interestingly, our results showed that more left BIDPs were causally associated with BMD, especially within and around the left frontal region. In conclusion, a part of brain structure causally influences BMD, which may provide important perspectives for the prevention of osteoporosis and offer valuable insights for further research of the brain-bone axis.
Publisher
Research Square Platform LLC
Reference75 articles.
1. Epidemiology, etiology, and diagnosis of osteoporosis;Lane NE;Am J Obstet Gynecol,2006
2. Risk factors for osteoporosis and associated fractures;Kelsey JL;Public Health Rep,1989
3. Clinical Practice. Postmenopausal Osteoporosis;Black DM;N Engl J Med,2016
4. Targeting skeletal endothelium to ameliorate bone loss;Xu R;Nat Med,2018
5. Evolving concepts in neurogenic osteoporosis;Qin W;Curr Osteoporos Rep,2010